Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia
- PMID: 37400487
- PMCID: PMC10474079
- DOI: 10.1038/s41431-023-01417-6
Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia
Conflict of interest statement
The authors have no direct pecuniary interests in the outputs of the study. ZS is employed by a genomics laboratory. The study is not supported by dedicated funding. The primary author is supported in his research activities by ongoing employment with the state government.
Figures
References
-
- Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–74. doi: 10.1038/gim.2016.221. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
